日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Randomized Phase II Study of Nab-Paclitaxel and Gemcitabine With or Without Tocilizumab as First-Line Treatment in Advanced Pancreatic Cancer: Survival and Cachexia

一项随机II期研究比较了紫杉醇纳米粒联合吉西他滨（加或不加托珠单抗）作为晚期胰腺癌一线治疗方案的疗效：生存率和恶病质

期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.23.01965
Chen, Inna M; Johansen, Julia S; Theile, Susann; Silverman, Libbie M; Pelz, Katherine R; Madsen, Kasper; Dajani, Olav; Lim, Kevin Z M; Lorentzen, Torben; Gaafer, Omnia; Koniaris, Leonidas G; Ferreira, Anna C; Neelon, Brian; Guttridge, Denis C; Ostrowski, Michael C; Zimmers, Teresa A; Nielsen, Dorte
胰腺癌
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Genome-wide analyses of cell-free DNA for therapeutic monitoring of patients with pancreatic cancer

利用游离DNA进行全基因组分析，以监测胰腺癌患者的治疗效果

期刊:Science Advances
影响因子:12.5
doi:10.1126/sciadv.ads5002
Hruban, Carolyn; Bruhm, Daniel C; Chen, Inna M; Koul, Shashikant; Annapragada, Akshaya V; Vulpescu, Nicholas A; Short, Sarah; Theile, Susann; Boyapati, Kavya; Alipanahi, Bahar; Skidmore, Zachary L; Leal, Alessandro; Cristiano, Stephen; Adleff, Vilmos; Johannsen, Julia S; Scharpf, Robert B; Foda, Zachariah H; Phallen, Jillian; Velculescu, Victor E
胰腺癌
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

The Prognostic Impact of Early ctDNA Kinetics in Metastatic Pancreatic Cancer Using the ctDNA-RECIST

利用ctDNA-RECIST评估早期ctDNA动力学对转移性胰腺癌预后的影响

期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-25-0758
Steiniche, Mette M; Lindgaard, Sidsel C; Chen, Inna M; Johansen, Julia S; Andersen, Rikke F; Hansen, Torben F; Jensen, Lars H; Rasmussen, Louise S; Johansen, Malene W; Ladekarl, Morten; Jakobsen, Anders K M; Spindler, Karen-Lise G
胰腺癌
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Proteolytic degradation of Beta-Ig H3 (βigH3/TGFBI) can be quantified non-invasively in serum and predicts prognosis in patients with advanced pancreatic ductal adenocarcinoma.

β-Ig H3 (βigH3/TGFBI) 的蛋白水解降解可以在血清中进行无创定量，并可预测晚期胰腺导管腺癌患者的预后

期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-025-14283-w
Pedersen Rasmus S, Hettich Annika, Thorlacius-Ussing Jeppe, Langholm Lasse L, Crespo-Bravo Marina, Chen Inna M, Hansen Carsten P, Johansen Julia S, Diab Hadi M H, Jorgensen Lars N, Karsdal Morten, Willumsen Nicholas
肿瘤
H3
发表日期：2025
文献求助 收藏

Promoter hypermethylation of SFRP1 is an allele fraction-dependent prognostic biomarker in metastatic pancreatic ductal adenocarcinoma

SFRP1启动子高甲基化是转移性胰腺导管腺癌中一种等位基因频率依赖性的预后生物标志物

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2025.1568386
Stubbe, Benjamin; Stoico, Malene P; Terp, Simone K; Madsen, Poul H; Lundbye-Christensen, Søren; Hansen, Carsten P; Poulsen, Laurids Ø; Rasmussen, Louise S; Yilmaz, Mette N; Jensen, Lars H; Hansen, Torben F; Pfeiffer, Per; Larsen, Anders C; Krarup, Henrik B; Pedersen, Inge S; Hasselby, Jane P; Johansen, Astrid Z; Chen, Inna M; Johansen, Julia S; Thorlacius-Ussing, Ole; Henriksen, Stine D
肿瘤
表观遗传
肿瘤免疫
发表日期：2025
文献求助 收藏

Transition of Online Adaptive Stereotactic Radiotherapy for Pancreatic Cancer From Magnetic Resonance-Guided Linear Accelerator (MR-Linac) to State-of-the-Art Cone-Beam Computed Tomography (CBCT)

胰腺癌在线自适应立体定向放射治疗从磁共振引导直线加速器（MR-Linac）过渡到最先进的锥形束计算机断层扫描（CBCT）

期刊:Cureus Journal of Medical Science
影响因子:1.3
doi:10.7759/cureus.68386
Rechner, Laura A; Felter, Mette; Bekke, Susanne; Biancardo, Susan; Rønjom, Marianne F; Pedersen, Mette; Sjöström, David; Chen, Inna M; Sibolt, Patrik
胰腺癌
肿瘤
肿瘤免疫
发表日期：2024
文献求助 收藏

Pre-existing TGF-β-specific T-cell immunity in patients with pancreatic cancer predicts survival after checkpoint inhibitors combined with radiotherapy

胰腺癌患者体内预先存在的TGF-β特异性T细胞免疫可预测免疫检查点抑制剂联合放疗后的生存期

期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2022-006432
Mortensen, Rasmus Erik Johansson; Holmström, Morten Orebo; Lisle, Thomas Landkildehus; Hasselby, Jane P; Willemoe, Gro L; Met, Özcan; Marie Svane, Inge; Johansen, Julia; Nielsen, Dorte L; Chen, Inna M; Andersen, Mads Hald
肿瘤
T细胞
肿瘤免疫
细胞生物学
TGF-β
T细胞
胰腺癌
免疫/内分泌
发表日期：2023
文献求助 收藏

Development and validation of circulating protein signatures as diagnostic biomarkers for biliary tract cancer

开发和验证循环蛋白特征作为胆道癌诊断生物标志物

期刊:Jhep Reports
影响因子:7.5
doi:10.1016/j.jhepr.2022.100648
Christensen, Troels D; Maag, Emil; Larsen, Ole; Feltoft, Claus L; Nielsen, Kaspar René; Jensen, Lars Henrik; Leerhøy, Bonna; Hansen, Carsten P; Chen, Inna M; Nielsen, Dorte L; Johansen, Julia S
肿瘤
胆管癌
肿瘤免疫
发表日期：2023
文献求助 收藏

Pancreatic cancer symptom trajectories from Danish registry data and free text in electronic health records

基于丹麦登记数据和电子健康记录中自由文本的胰腺癌症状轨迹

期刊:Elife
影响因子:6.4
doi:10.7554/eLife.84919
Hjaltelin, Jessica Xin; Novitski, Sif Ingibergsdóttir; Jørgensen, Isabella Friis; Siggaard, Troels; Vulpius, Siri Amalie; Westergaard, David; Johansen, Julia Sidenius; Chen, Inna M; Juhl Jensen, Lars; Brunak, Søren
胰腺癌
肿瘤
肿瘤免疫
发表日期：2023
文献求助 收藏

Protein Signatures and Individual Circulating Proteins, including IL-6 and IL-15, Associated with Prognosis in Patients with Biliary Tract Cancer

蛋白质特征和特定循环蛋白（包括IL-6和IL-15）与胆道癌患者的预后相关

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers15041062
Christensen, Troels D; Madsen, Kasper; Maag, Emil; Larsen, Ole; Jensen, Lars Henrik; Hansen, Carsten P; Markussen, Alice; Høgdall, Dan T S; Chen, Inna M; Nielsen, Dorte; Johansen, Julia S
肿瘤
肿瘤免疫
胆管癌
IL-6
IL-15
发表日期：2023
文献求助 收藏